Brighton Jones LLC’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.7M | Buy |
+27,052
| New | +$1.88M | 0.04% | 308 |
|
|
2025
Q4 | – | Sell |
-18,013
| Closed | -$1.21M | – | 298 |
|
|
2025
Q3 | $1.21M | Buy |
18,013
+96
| +0.5% | +$7.6K | 0.03% | 346 |
|
|
2025
Q2 | $1.56M | Buy |
17,917
+908
| +5% | +$71.2K | 0.04% | 229 |
|
|
2025
Q1 | $1.16M | Buy |
17,009
+427
| +3% | +$34.8K | 0.04% | 239 |
|
|
2024
Q4 | $1.29M | Buy |
16,582
+11,946
| +258% | +$884K | 0.04% | 219 |
|
|
2024
Q3 | $311K | Sell |
4,636
-247
| -5% | -$20.3K | 0.01% | 421 |
|
|
2024
Q2 | $554K | Sell |
4,883
-4
| -0.1% | -$506 | 0.02% | 334 |
|
|
2024
Q1 | $678K | Sell |
4,887
-5
| -0.1% | -$628 | 0.02% | 289 |
|
|
2023
Q4 | $607K | Buy |
4,892
+28
| +0.6% | +$2.86K | 0.03% | 285 |
|
|
2023
Q3 | $454K | Buy |
4,864
+164
| +3% | +$18.5K | 0.02% | 310 |
|
|
2023
Q2 | $604K | Buy |
4,700
+116
| +3% | +$14K | 0.03% | 266 |
|
|
2023
Q1 | $533K | Buy |
4,584
+23
| +0.5% | +$2.58K | 0.03% | 275 |
|
|
2022
Q4 | $516K | Buy |
4,561
+55
| +1% | +$6.04K | 0.03% | 244 |
|
|
2022
Q3 | $363K | Buy |
4,506
+51
| +1% | +$4.32K | 0.02% | 296 |
|
|
2022
Q2 | $332K | Sell |
4,455
-165
| -4% | -$15.1K | 0.02% | 317 |
|
|
2022
Q1 | $591K | Sell |
4,620
-8
| -0.2% | -$875 | 0.03% | 249 |
|
|
2021
Q4 | $621K | Sell |
4,628
-344
| -7% | -$49.4K | 0.03% | 237 |
|
|
2021
Q3 | $680K | Sell |
4,972
-556
| -10% | -$70.1K | 0.04% | 211 |
|
|
2021
Q2 | $590K | Buy |
5,528
+656
| +13% | +$63K | 0.03% | 229 |
|
|
2021
Q1 | $438K | Sell |
4,872
-48
| -1% | -$4.51K | 0.03% | 248 |
|
|
2020
Q4 | $455K | Sell |
4,920
-504
| -9% | -$45K | 0.03% | 223 |
|
|
2020
Q3 | $559K | Sell |
5,424
-212
| -4% | -$22.1K | 0.04% | 178 |
|
|
2020
Q2 | $571K | Sell |
5,636
-860
| -13% | -$76.9K | 0.05% | 161 |
|
|
2020
Q1 | $437K | Buy |
6,496
+988
| +18% | +$61.5K | 0.05% | 176 |
|
|
2019
Q4 | $301K | Sell |
5,508
-32
| -0.6% | -$1.52K | 0.03% | 245 |
|
|
2019
Q3 | $207K | Sell |
5,540
-40
| -0.7% | -$1.55K | 0.02% | 293 |
|
|
2019
Q2 | $209K | Buy |
+5,580
| New | +$175K | 0.02% | 286 |
|
|
2018
Q4 | – | Sell |
-5,716
| Closed | -$204K | – | 269 |
|
|
2018
Q3 | $204K | Buy |
+5,716
| New | +$177K | 0.03% | 269 |
|
|
2017
Q2 | – | Sell |
-9,644
| Closed | -$204K | – | 279 |
|
|
2017
Q1 | $204K | Buy |
+9,644
| New | +$188K | 0.05% | 98 |
|
|
2016
Q4 | – | Sell |
-11,388
| Closed | -$250K | – | 133 |
|
|
2016
Q3 | $250K | Buy |
+11,388
| New | +$253K | 0.04% | 200 |
|
Other funds holding DXCM
VCM
VPM
Brighton Jones LLC's DXCM Position: Q1 2026 in Review
Brighton Jones LLC opened a new position in DexCom (DXCM) in Q1 2026: 27,052 shares worth $1.7M. The stake represents 0.04% of the portfolio and ranks #308 among its holdings. This is a return to the name: Brighton Jones LLC previously reported a position in DXCM as recently as Q3 2025.
Brighton Jones LLC first reported a position in DXCM in Q3 2016 and has held it in 30 quarters since. 959 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Brighton Jones LLC held 27,052 shares of DexCom worth $1.7M as of Q1 2026.
- DexCom was a new Brighton Jones LLC position in Q1 2026.
- DexCom made up 0.04% of Brighton Jones LLC's portfolio in Q1 2026, its #308 holding.
- Brighton Jones LLC first reported a position in DexCom in Q3 2016 and has held it in 30 quarters since.
- 959 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Brighton Jones LLC's 13F filing for Q1 2026, filed 28 Apr 2026.